Epidemiologist Resume Examples by Level (2026)

Epidemiologist Resume Examples: Proven Templates That Get Interviews in 2025

The Bureau of Labor Statistics projects 16% employment growth for epidemiologists through 2034 — more than triple the national average — yet most applicants sabotage their candidacy with resumes that read like academic CVs instead of impact-driven career documents. With only 800 openings projected annually across roughly 12,300 positions nationwide, every line on your resume must demonstrate both methodological rigor and measurable public health outcomes.

TL;DR

Epidemiologist resumes must balance technical depth (SAS, R, Stata, REDCap) with quantified population-level impact. Hiring managers at agencies like the CDC, state health departments, and pharmaceutical companies scan for study design expertise, IRB navigation, and real-world disease burden reductions — not just publications. The three resume examples below cover entry-level (state health department), mid-career (federal/NGO), and senior (pharmaceutical/academic) trajectories, each loaded with the specific metrics and ATS keywords that move applications past automated screening.

Why This Role Matters

Epidemiologists are the frontline architects of public health decision-making. The COVID-19 pandemic permanently elevated the profession's visibility, but the demand pipeline extends far beyond infectious disease: chronic disease surveillance, pharmacovigilance, environmental health, and the emerging field of AI-driven epidemic intelligence all rely on epidemiologists who can design studies, analyze population data, and translate findings into policy. **Key labor market data (BLS, May 2024):** - **Median annual wage:** $83,980 (ranges from $56,950 at the 10th percentile to $134,860 at the 90th) - **Employment:** ~12,300 jobs nationally - **Growth rate:** 16% through 2034 (much faster than average) - **Annual openings:** ~800 per year - **Top-paying sector:** Scientific research and development — $130,390 median - **Hospital settings:** $99,690 median - **Federal government:** $91,086 average (up to $162,298 at 90th percentile) - **State government:** $79,640 median - **Colleges and universities:** $80,640 median The takeaway: your resume must position you for the sector you want. A pharmaceutical epidemiologist earning $130K+ needs different emphasis than a state surveillance officer at $79K — even though both share core competencies.

Resume Example 1: Entry-Level Epidemiologist (State Health Department)

**Sarah Chen, MPH** Atlanta, GA | [email protected] | (404) 555-0192 | linkedin.com/in/sarahchenmphepi

Professional Summary

CDC Epidemic Intelligence Service (EIS)-trained epidemiologist with an MPH in Epidemiology from Emory University and 2 years of field experience investigating communicable disease outbreaks across 12 Georgia counties. Led contact tracing operations for 3 concurrent outbreaks affecting 4,200+ individuals, achieving 89% contact completion rate within 48-hour windows. Proficient in SAS 9.4, R, and REDCap with 4 peer-reviewed publications on respiratory illness surveillance.

Work Experience

**Epidemiologist I** Georgia Department of Public Health — Atlanta, GA | June 2023 – Present - Investigated 47 disease outbreaks across 12 counties in 18 months, including 8 foodborne, 14 respiratory, and 25 communicable disease clusters, submitting final reports to the state epidemiologist within 14-day average turnaround - Designed and deployed a REDCap-based case investigation form adopted by 6 district health offices, reducing duplicate data entry by 34% and improving field data completeness from 71% to 93% - Conducted a matched case-control study (N=312) of a Salmonella Typhimurium outbreak linked to a multi-county restaurant chain, identifying the exposure source within 9 days and preventing an estimated 150 additional cases - Analyzed 5 years of syndromic surveillance data (2.1 million ED visits) using SAS 9.4 to identify seasonal patterns in influenza-like illness, producing weekly epi-curve reports distributed to 159 county health departments - Coordinated contact tracing for a measles cluster (38 confirmed cases) across 3 school districts, achieving 96% contact enumeration and contributing to containment within 4 weeks - Developed an automated R Shiny dashboard displaying real-time STI incidence rates by census tract for 10 metro-Atlanta counties, viewed 1,200+ times monthly by local health directors - Authored 4 MMWR-style surveillance summaries and co-authored 2 peer-reviewed publications in the Journal of Infectious Diseases and Emerging Infectious Diseases **EIS Fellow (Epidemic Intelligence Service)** Centers for Disease Control and Prevention — Atlanta, GA | July 2021 – June 2023 - Completed 2-year post-doctoral fellowship in the Division of Foodborne, Waterborne, and Environmental Diseases, responding to 11 outbreak investigations across 7 states - Led a multi-state investigation of Cyclospora cayetanensis linked to imported produce, coordinating specimen collection from 214 confirmed cases across 4 states and tracing the supply chain to 3 distribution centers - Built logistic regression models in Stata 17 to assess risk factors for severe Clostridioides difficile infection in a cohort of 1,847 hospitalized patients, identifying 3 independent predictors (OR range: 2.1–4.8) - Designed and administered a cross-sectional survey (n=2,400, 68% response rate) to assess COVID-19 vaccine hesitancy in underserved rural communities across southeastern U.S., informing CDC messaging strategy - Presented findings at the annual EIS Conference and the Council of State and Territorial Epidemiologists (CSTE) conference, receiving the EIS Outstanding Investigation Award for the Cyclospora study

Education

**Master of Public Health (MPH), Epidemiology** Emory University, Rollins School of Public Health — Atlanta, GA | 2021 - Concentration: Infectious Disease Epidemiology - Thesis: "Geospatial Analysis of Invasive Group A Streptococcus in Metropolitan Atlanta, 2015–2020" (published in Epidemiology & Infection) **Bachelor of Science, Biology** University of Georgia — Athens, GA | 2019 - Summa Cum Laude, GPA: 3.91/4.0

Certifications

• Certified in Public Health (CPH) — National Board of Public Health Examiners, 2022
• SAS Certified Clinical Trials Programmer — SAS Institute, 2023

Technical Skills

SAS 9.4 | R (tidyverse, ggplot2, epiR, survival) | Stata 17 | REDCap | ArcGIS Pro | SPSS | SQL | National Electronic Disease Surveillance System (NEDSS) | BioSense Platform | Epi Info 7 | Python (pandas, scipy)

Resume Example 2: Mid-Career Epidemiologist (Federal Agency / Global Health)

**Marcus Williams, PhD, MPH, CPH** Bethesda, MD | [email protected] | (301) 555-0847 | linkedin.com/in/marcuswilliamsepi

Professional Summary

Senior epidemiologist with 8 years of experience leading infectious disease surveillance programs at the NIH National Institute of Allergy and Infectious Diseases (NIAID) and the World Health Organization. Directed a 14-country respiratory pathogen surveillance network generating 480,000+ specimen records annually, with findings cited in 3 WHO policy guidelines. Published 22 peer-reviewed articles (h-index: 14) with expertise in cohort study design, survival analysis, and genomic epidemiology. Holds CPH certification and an active Secret security clearance.

Work Experience

**Senior Research Epidemiologist (GS-14)** National Institute of Allergy and Infectious Diseases (NIAID), NIH — Bethesda, MD | March 2021 – Present - Lead epidemiologic design and analysis for 4 multi-site clinical trials (combined enrollment: 8,200 participants) evaluating next-generation respiratory vaccines, managing $3.2M in direct research costs - Directed data safety monitoring for a Phase III RSV vaccine trial (N=4,600), developing interim analysis plans reviewed by the DSMB and contributing to FDA Emergency Use Authorization submission - Built a Cox proportional hazards model analyzing 36-month follow-up data from a longitudinal cohort (N=12,400), identifying 5 independent predictors of long COVID syndrome with a C-statistic of 0.78 - Designed the sampling framework for a national seroprevalence study spanning 42 sites across 28 states, achieving 94% target enrollment (18,700 of 20,000) within 9-month collection window - Supervised 6 post-doctoral fellows and 3 research analysts, conducting weekly code review sessions that reduced data processing errors by 62% over 12 months - Co-authored NIH strategic plan section on pandemic preparedness surveillance infrastructure, adopted by the NIAID Council in December 2024 - Published 9 first- or senior-author papers during tenure, including 2 in The Lancet Infectious Diseases (combined citations: 340+) **Epidemiologist, Health Emergencies Programme** World Health Organization — Geneva, Switzerland | January 2018 – February 2021 - Managed the Global Influenza Surveillance and Response System (GISRS) data pipeline for 14 countries in the Eastern Mediterranean and South-East Asia regions, processing 480,000+ specimen records per year - Coordinated field investigations for 7 disease outbreaks including MERS-CoV (Saudi Arabia, 2019), cholera (Yemen, 2020), and COVID-19 initial response (multiple countries), deploying within 48 hours of notification - Developed a Bayesian nowcasting model in R to estimate real-time COVID-19 case fatality ratios across 8 countries, published in the Bulletin of the World Health Organization and cited in WHO interim guidance - Trained 120+ national epidemiologists from 22 countries through the WHO Field Epidemiology Training Program (FETP), delivering 14 week-long workshops on outbreak investigation methodology - Led the epidemiologic analysis for a WHO rapid risk assessment of pandemic H5N1 avian influenza that informed stockpile deployment decisions for 6 member states - Established data-sharing agreements with 9 national reference laboratories, reducing specimen-to-result reporting time from 21 days to 7 days **Epidemiologist** Maryland Department of Health — Baltimore, MD | August 2016 – December 2017 - Conducted surveillance and case investigations for 340+ reportable disease cases monthly, maintaining 97% timeliness for CDC-required reporting - Performed a retrospective cohort study (N=2,100) of opioid-related ED visits in Baltimore City, demonstrating a 28% increase in fentanyl-positive toxicology screens from 2015 to 2017, informing the city's naloxone distribution policy - Created automated SAS macros that reduced weekly surveillance report generation time from 6 hours to 45 minutes, adopted by 4 neighboring jurisdictions

Education

**Doctor of Philosophy (PhD), Epidemiology** Johns Hopkins Bloomberg School of Public Health — Baltimore, MD | 2016 - Dissertation: "Molecular Epidemiology of Multi-Drug Resistant Tuberculosis in South-East Asia: A Whole-Genome Sequencing Analysis of 2,400 Clinical Isolates" **Master of Public Health (MPH), International Health** Johns Hopkins Bloomberg School of Public Health — Baltimore, MD | 2012 **Bachelor of Science, Microbiology** University of Maryland — College Park, MD | 2010

Certifications

• Certified in Public Health (CPH) — NBPHE, 2017 (renewed 2023)
• Good Clinical Practice (GCP) — CITI Program, 2024
• Certified in Infection Control (CIC) — CBIC, 2019

Technical Skills

R (survival, brms, rstanarm, shiny, rmarkdown) | SAS 9.4 | Stata 17 | Python (scikit-learn, statsmodels) | SQL (PostgreSQL, Oracle) | REDCap | DHIS2 | ArcGIS Pro | QGIS | Nextclade/Nextstrain (genomic epi) | ICD-10 coding | TrialMaster | Medidata Rave

Selected Publications (22 total; h-index: 14)

1. Williams M, et al. "Real-time case fatality estimation during the early COVID-19 pandemic across 8 countries." *Bulletin of the WHO*, 2021.
2. Williams M, et al. "Genomic diversity of MERS-CoV in the Eastern Mediterranean Region, 2018-2020." *The Lancet Infectious Diseases*, 2022.
3. Williams M, et al. "Predictors of long COVID in a U.S. longitudinal cohort: A 36-month follow-up." *The Lancet Infectious Diseases*, 2024.

Resume Example 3: Senior Epidemiologist (Pharmaceutical / Biotech)

**Dr. Priya Ramanathan, ScD, CPH** Cambridge, MA | [email protected] | (617) 555-0413 | linkedin.com/in/priyaramepidemiologist

Professional Summary

Director-level pharmacoepidemiologist with 12 years of experience spanning Pfizer, IQVIA, and academic research, leading post-market safety studies and real-world evidence (RWE) programs that have directly informed 4 FDA label updates and 2 REMS modifications. Managed cross-functional teams of up to 18 across 6 countries while overseeing $8.5M in combined annual study budgets. Expert in claims database analysis (Optum, MarketScan, CPRD), self-controlled case series design, and signal detection methodologies. 31 peer-reviewed publications (h-index: 19).

Work Experience

**Director, Epidemiology & Real-World Evidence** Pfizer Inc. — Cambridge, MA | April 2021 – Present - Lead a team of 12 epidemiologists, biostatisticians, and data scientists executing Pfizer's post-authorization safety surveillance for 6 marketed products, managing $5.2M annual operating budget - Designed and led a self-controlled case series study (N=2.8 million vaccinated individuals) evaluating myocarditis risk following COVID-19 mRNA vaccination, with results published in JAMA and cited 680+ times - Directed 3 concurrent post-marketing requirement (PMR) studies mandated by the FDA, delivering all interim analyses on schedule and contributing to updated prescribing information for 2 oncology products - Built Pfizer's first AI-assisted signal detection pipeline using Python (scikit-learn, XGBoost) applied to FAERS data, identifying 14 potential safety signals 40% faster than traditional disproportionality analysis - Negotiated data licensing agreements with Optum ($1.8M/year) and CPRD ($420K/year), establishing Pfizer's RWE data infrastructure for 4 therapeutic areas - Authored 6 FDA regulatory submissions (periodic safety update reports and aggregate safety evaluations), with zero major deficiency findings across 3 review cycles - Mentored 4 junior epidemiologists and 2 postdoctoral fellows, with 3 advancing to senior roles within 24 months - Served as epidemiology representative on Pfizer's Global Safety Board, reviewing benefit-risk assessments for 8 compounds quarterly **Senior Epidemiologist** IQVIA Real World Solutions — Durham, NC | June 2017 – March 2021 - Led pharmacoepidemiology studies for 9 pharmaceutical clients across oncology, immunology, and rare disease therapeutic areas, generating $4.1M in annual consulting revenue - Designed a nested case-control study (N=48,000) within MarketScan claims data assessing cardiovascular outcomes associated with a JAK inhibitor, with findings incorporated into the FDA-mandated REMS program - Built propensity score-matched cohorts (N=22,000 matched pairs) using Optum EHR data to evaluate comparative effectiveness of biologic vs. conventional DMARD therapy in rheumatoid arthritis, published in Annals of Internal Medicine - Developed standardized analysis templates in SAS that reduced study setup time by 30% across IQVIA's epidemiology practice, adopted by 45 team members in 3 offices - Presented results at 12 international conferences including ICPE (International Conference on Pharmacoepidemiology), DIA, and ISPE, with 3 presentations selected for oral sessions **Epidemiologist, Center for Drug Evaluation and Research (CDER)** U.S. Food and Drug Administration — Silver Spring, MD | August 2013 – May 2017 - Reviewed epidemiologic study protocols and results for 24 post-marketing safety commitments across 6 therapeutic areas, ensuring compliance with FDA guidance on pharmacoepidemiologic study design - Conducted signal evaluation for 18 drug-event combinations using the FDA Sentinel System (Mini-Sentinel), applying tree-based scan statistics and sequential analysis methods - Co-authored 3 FDA Drug Safety Communications based on epidemiologic evidence, including a boxed warning update affecting an estimated 2.4 million U.S. prescriptions annually - Developed internal training materials on self-controlled case series and new-user cohort study designs, delivered to 40+ reviewers in the Office of Surveillance and Epidemiology

Education

**Doctor of Science (ScD), Epidemiology** Harvard T.H. Chan School of Public Health — Boston, MA | 2013 - Dissertation: "Comparative Safety of Anticoagulant Therapy in Atrial Fibrillation: A Multi-Database Pharmacoepidemiologic Study Using Propensity Score Methods" - Cabot Award for Outstanding Doctoral Dissertation **Master of Public Health (MPH), Quantitative Methods** Harvard T.H. Chan School of Public Health — Boston, MA | 2009 **Bachelor of Science, Statistics** University of California, Berkeley — Berkeley, CA | 2007 - Phi Beta Kappa

Certifications

• Certified in Public Health (CPH) — NBPHE, 2014 (renewed 2024)
• Good Pharmacovigilance Practice (GVP) — Drug Information Association, 2022
• SAS Certified Advanced Programmer — SAS Institute, 2018

Technical Skills

SAS 9.4 (Base, STAT, Graph, Macro) | R (survival, MatchIt, cobalt, meta, brms) | Python (scikit-learn, XGBoost, pandas, lifelines) | SQL (Teradata, Redshift, BigQuery) | Optum CDM | MarketScan | CPRD GOLD/Aurum | FDA Sentinel System | FAERS/AERS | Aetion Evidence Platform | Medidata Rave | OMOP CDM | Spotfire | Tableau

Selected Publications (31 total; h-index: 19)

1. Ramanathan P, et al. "Myocarditis risk following mRNA COVID-19 vaccination: A self-controlled case series in 2.8 million recipients." *JAMA*, 2023.
2. Ramanathan P, et al. "Comparative cardiovascular safety of JAK inhibitors: A nested case-control study in U.S. claims data." *Annals of Internal Medicine*, 2020.
3. Ramanathan P, et al. "Propensity score methods in pharmacoepidemiology: A practical guide for real-world evidence generation." *Pharmacoepidemiology and Drug Safety*, 2019.

ATS Keywords for Epidemiologist Resumes

Incorporate these terms naturally throughout your resume to pass automated screening: | Category | Keywords | |----------|----------| | **Study Design** | cohort study, case-control study, cross-sectional study, ecological study, self-controlled case series, randomized controlled trial, nested case-control, matched cohort, retrospective analysis, prospective surveillance | | **Statistical Methods** | logistic regression, Cox proportional hazards, survival analysis, propensity score matching, Bayesian analysis, meta-analysis, time-series analysis, Kaplan-Meier, Poisson regression, disproportionality analysis | | **Software & Tools** | SAS, R, Stata, SPSS, Python, REDCap, ArcGIS, QGIS, SQL, Epi Info | | **Databases & Systems** | NEDSS, FAERS, Sentinel System, Optum, MarketScan, CPRD, BioSense Platform, DHIS2, OMOP CDM | | **Domain Expertise** | outbreak investigation, disease surveillance, pharmacovigilance, real-world evidence, contact tracing, seroprevalence, genomic epidemiology, field epidemiology, pharmacoepidemiology, signal detection | | **Regulatory & Process** | IRB protocol, HIPAA compliance, Good Clinical Practice, ICD-10, FDA submission, post-marketing surveillance, REMS, informed consent, data use agreement |

Skills Breakdown

Hard Skills (Must-Have)